Related Experiment Videos
Antiphospholipid antibodies activate vascular endothelial cells
R Simantov1, S K Lo, A Gharavi
1Division of Hematology/Oncology, Cornell University Medical College, New York, NY, 10021, USA.
Lupus
|October 1, 1996
Summary
Antiphospholipid antibodies (aPL) activate vascular endothelial cells, promoting thrombosis. This endothelial activation, dependent on beta 2-glycoprotein I, contributes to the hypercoagulable state seen in antiphospholipid syndrome.
Area of Science:
- Immunology
- Vascular Biology
- Thrombosis Research
Background:
- Antiphospholipid antibodies (aPL) are linked to thrombosis and pregnancy loss.
- The pro-thrombotic mechanisms of aPL are not fully understood.
- Vascular endothelial cells (EC) play a critical role in hemostasis.
Purpose of the Study:
- To investigate the effect of IgG from aPL patients on EC.
- To determine the role of beta 2-glycoprotein I (β2GPI) in aPL-induced EC activation.
- To elucidate the specific mechanisms of EC activation by aPL.
Main Methods:
- Purification of IgG from patients with aPL.
- Incubation of EC with purified IgG.
- Assessment of EC activation markers (ICAM-1, VCAM, E-selectin) via flow cytometry.
- Control experiments to rule out endotoxin, Fc receptor, and immune complex involvement.
Main Results:
- IgG from aPL patients activated EC, inducing a pro-thrombotic surface.
- Activated EC expressed leukocyte adhesion molecules: ICAM-1, VCAM, and E-selectin.
- EC activation was dependent on the presence of β2GPI.
- Activation was specifically due to anticardiolipin reactivity, not other factors.
Conclusions:
- aPL-activated EC exhibit pro-thrombotic properties.
- β2GPI is essential for aPL-induced endothelial activation.
- Specific anticardiolipin IgG reactivity drives endothelial activation, contributing to the hypercoagulable state in antiphospholipid syndrome.